Overview
SCIENTIFIC SCORE
Possibly Effective
Based on 5 Researches
7.9
USERS' SCORE
Good
Based on 12 Reviews
8.5
Supplement Facts
Serving Size: 1 Softgel
Amount Per Serving
%DV
Calories
15
Total Fat
1.5 g
2%**
Wild Caught Fish Oil Concentrate
1250 mg
†
Total Omega-3 Fatty Acids as TG
1055 mg
†
EPA (Eicosapentaenoic Acid)
690 mg
†
DHA (Docosahexaenoic Acid)
310 mg
†
Other Omega-3 Fatty Acids
55 mg
†
Top Medical Research Studies
9.5
We explored the potential benefits of eicosapentaenoic acid (EPA), an essential fatty acid, in treating chronic fatigue syndrome (CFS). A female patient with a six-year history of persistent CFS symptoms participated in the study, receiving a daily supplement rich in EPA.
After measuring her brain structure through high-resolution magnetic resonance imaging both at the beginning and 16 weeks later, we observed significant improvements in her symptoms starting just six to eight weeks into the treatment. Most notably, the patient's lateral ventricular volume—a key indicator of brain health—decreased from 28,940 mm³ to 23,660 mm³, indicating structural changes in her brain.
This research hints at the promising role of EPA in alleviating symptoms of chronic fatigue syndrome while also suggesting positive brain changes associated with treatment. The findings encourage further investigation into fatty acid supplementation's potential as an effective therapeutic strategy for CFS.
After measuring her brain structure through high-resolution magnetic resonance imaging both at the beginning and 16 weeks later, we observed significant improvements in her symptoms starting just six to eight weeks into the treatment. Most notably, the patient's lateral ventricular volume—a key indicator of brain health—decreased from 28,940 mm³ to 23,660 mm³, indicating structural changes in her brain.
This research hints at the promising role of EPA in alleviating symptoms of chronic fatigue syndrome while also suggesting positive brain changes associated with treatment. The findings encourage further investigation into fatty acid supplementation's potential as an effective therapeutic strategy for CFS.
Read More
9
Eicosapentaenoic acid shows promise
We examined the link between chronic fatigue syndrome (CFS) and essential fatty acids, focusing specifically on eicosapentaenoic acid (EPA). This investigation arose from various studies highlighting the potential role essential fatty acids play in alleviating symptoms associated with CFS.
Our approach involved administering a high-EPA supplementation to a group of individuals diagnosed with chronic fatigue syndrome. After following these patients for eight to twelve weeks, we observed that all participants experienced notable improvements in their symptoms.
These positive changes align with recent findings that discuss both cerebral and clinical benefits tied to increased EPA intake. Given these encouraging results, eicosapentaenoic acid may ultimately provide hope for many suffering from chronic fatigue syndrome.
Our approach involved administering a high-EPA supplementation to a group of individuals diagnosed with chronic fatigue syndrome. After following these patients for eight to twelve weeks, we observed that all participants experienced notable improvements in their symptoms.
These positive changes align with recent findings that discuss both cerebral and clinical benefits tied to increased EPA intake. Given these encouraging results, eicosapentaenoic acid may ultimately provide hope for many suffering from chronic fatigue syndrome.
Read More
4
We examined the impact of omega-3 polyunsaturated fatty acids, particularly eicosapentaenoic acid (EPA), on chronic fatigue syndrome (CFS). Our research included 22 CFS patients and 12 healthy controls, where we measured serum levels of these fatty acids using advanced techniques.
Our findings revealed that CFS patients had elevated levels of omega-6 fatty acids while showing significantly lower ratios of omega-3 to omega-6. This imbalance was closely linked to the severity of CFS symptoms like fatigue and memory issues. We also found interesting connections between lower omega-3 levels and reduced serum zinc, hinting at immune system challenges present in CFS.
Notably, the study suggests that a decrease in omega-3 fatty acids could influence the immune response in those suffering from CFS. This outcome opens avenues for potential treatment strategies using omega-3 supplements like EPA. However, we did not have direct evidence of treatment outcomes, so while the results are promising, further investigation is needed to clarify how effective eicosapentaenoic acid might be as a treatment for CFS.
Our findings revealed that CFS patients had elevated levels of omega-6 fatty acids while showing significantly lower ratios of omega-3 to omega-6. This imbalance was closely linked to the severity of CFS symptoms like fatigue and memory issues. We also found interesting connections between lower omega-3 levels and reduced serum zinc, hinting at immune system challenges present in CFS.
Notably, the study suggests that a decrease in omega-3 fatty acids could influence the immune response in those suffering from CFS. This outcome opens avenues for potential treatment strategies using omega-3 supplements like EPA. However, we did not have direct evidence of treatment outcomes, so while the results are promising, further investigation is needed to clarify how effective eicosapentaenoic acid might be as a treatment for CFS.
Read More
Most Useful Reviews
9
Fatigue disappeared
103 people found this helpful
Excellent value for money and quality! I have taken this omega for over a month and it's given me a remarkable boost in energy throughout the day! As a parent, sleepless nights leave me feeling broken, but since I started this omega, my fatigue has vanished! Additionally, it has improved my skin and nails significantly!
Read More
9
Fatigue vanished
73 people found this helpful
I quickly wanted to share my review of this omega, having taken it for over a month. It's provided me an astounding energy boost daily! As a parent, I know sleep is often disrupted, leading to a tired feeling, but since taking this omega, my fatigue has disappeared. Plus, it's enhanced the condition of my skin and nails!
Read More
9
Fatigue relief
2 people found this helpful
As a doctor, I highly recommend this omega! It has the best DHA/EPA ratio, enhancing absorption. While pregnant, it completely alleviated my fatigue, and my skin has improved. It's also economical, lasting six months.
Read More
Medical Researches
SCIENTIFIC SCORE
Possibly Effective
Based on 5 Researches
7.9
- All Researches
9.5
We explored the potential benefits of eicosapentaenoic acid (EPA), an essential fatty acid, in treating chronic fatigue syndrome (CFS). A female patient with a six-year history of persistent CFS symptoms participated in the study, receiving a daily supplement rich in EPA.
After measuring her brain structure through high-resolution magnetic resonance imaging both at the beginning and 16 weeks later, we observed significant improvements in her symptoms starting just six to eight weeks into the treatment. Most notably, the patient's lateral ventricular volume—a key indicator of brain health—decreased from 28,940 mm³ to 23,660 mm³, indicating structural changes in her brain.
This research hints at the promising role of EPA in alleviating symptoms of chronic fatigue syndrome while also suggesting positive brain changes associated with treatment. The findings encourage further investigation into fatty acid supplementation's potential as an effective therapeutic strategy for CFS.
After measuring her brain structure through high-resolution magnetic resonance imaging both at the beginning and 16 weeks later, we observed significant improvements in her symptoms starting just six to eight weeks into the treatment. Most notably, the patient's lateral ventricular volume—a key indicator of brain health—decreased from 28,940 mm³ to 23,660 mm³, indicating structural changes in her brain.
This research hints at the promising role of EPA in alleviating symptoms of chronic fatigue syndrome while also suggesting positive brain changes associated with treatment. The findings encourage further investigation into fatty acid supplementation's potential as an effective therapeutic strategy for CFS.
Read More
9
Eicosapentaenoic acid shows promise
We examined the link between chronic fatigue syndrome (CFS) and essential fatty acids, focusing specifically on eicosapentaenoic acid (EPA). This investigation arose from various studies highlighting the potential role essential fatty acids play in alleviating symptoms associated with CFS.
Our approach involved administering a high-EPA supplementation to a group of individuals diagnosed with chronic fatigue syndrome. After following these patients for eight to twelve weeks, we observed that all participants experienced notable improvements in their symptoms.
These positive changes align with recent findings that discuss both cerebral and clinical benefits tied to increased EPA intake. Given these encouraging results, eicosapentaenoic acid may ultimately provide hope for many suffering from chronic fatigue syndrome.
Our approach involved administering a high-EPA supplementation to a group of individuals diagnosed with chronic fatigue syndrome. After following these patients for eight to twelve weeks, we observed that all participants experienced notable improvements in their symptoms.
These positive changes align with recent findings that discuss both cerebral and clinical benefits tied to increased EPA intake. Given these encouraging results, eicosapentaenoic acid may ultimately provide hope for many suffering from chronic fatigue syndrome.
Read More
9
Effective treatment for fatigue syndrome
We conducted a thorough investigation into the effects of essential fatty acids, including eicosapentaenoic acid (EPA), on individuals suffering from postviral fatigue syndrome. In a well-structured trial, 63 adults with this condition participated in a double-blind, placebo-controlled study. They had been living with severe fatigue and other troubling symptoms for one to three years following a viral infection.
Patients received either an active treatment containing EPA and other essential fatty acids or a placebo for three months. Their overall health, fatigue levels, and other symptoms were assessed at the beginning, after one month, and at the end of the study. Strikingly, we observed that 74% of those taking the essential fatty acids reported improvements after one month, rising to 85% after three months. In contrast, only 23% and 17% of the placebo group noted any benefit at those respective time points.
Notably, the fatty acid levels in the participants' red blood cells, which were abnormal at the beginning of the trial, showed significant improvement with the active treatment. Importantly, we found no adverse side effects from the treatment, leading us to conclude that essential fatty acids can be a safe and effective option for people dealing with postviral fatigue syndrome.
Patients received either an active treatment containing EPA and other essential fatty acids or a placebo for three months. Their overall health, fatigue levels, and other symptoms were assessed at the beginning, after one month, and at the end of the study. Strikingly, we observed that 74% of those taking the essential fatty acids reported improvements after one month, rising to 85% after three months. In contrast, only 23% and 17% of the placebo group noted any benefit at those respective time points.
Notably, the fatty acid levels in the participants' red blood cells, which were abnormal at the beginning of the trial, showed significant improvement with the active treatment. Importantly, we found no adverse side effects from the treatment, leading us to conclude that essential fatty acids can be a safe and effective option for people dealing with postviral fatigue syndrome.
Read More
8
Eicosapentaenoic acid's potential in CFS
We explored the connection between eicosapentaenoic acid (EPA) and chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis. The research indicates that individuals suffering from CFS may experience complications linked to persistent viral infections, which could hinder their body's ability to produce necessary fatty acids.
Specifically, the issue revolves around the enzyme delta-6 desaturase, which plays a critical role in the conversion of essential fatty acids like alpha-linolenic acid and linoleic acid into longer chain polyunsaturated fatty acids. These fatty acids are vital for maintaining healthy cell membranes and proper cell signaling. If their production is inhibited, it could explain many symptoms associated with CFS.
One intriguing aspect we observed is the potential therapeutic role that EPA could play. By providing EPA directly, we may bypass some of the metabolic restrictions caused by viral infections. This not only aids in generating essential fatty acids needed for bodily functions but also shows promise as a treatment option that could alleviate certain symptoms of CFS.
While the exact impact of EPA treatment on CFS warrants further investigation, the findings suggest that it might offer some benefits worth considering for those affected by this challenging condition.
Specifically, the issue revolves around the enzyme delta-6 desaturase, which plays a critical role in the conversion of essential fatty acids like alpha-linolenic acid and linoleic acid into longer chain polyunsaturated fatty acids. These fatty acids are vital for maintaining healthy cell membranes and proper cell signaling. If their production is inhibited, it could explain many symptoms associated with CFS.
One intriguing aspect we observed is the potential therapeutic role that EPA could play. By providing EPA directly, we may bypass some of the metabolic restrictions caused by viral infections. This not only aids in generating essential fatty acids needed for bodily functions but also shows promise as a treatment option that could alleviate certain symptoms of CFS.
While the exact impact of EPA treatment on CFS warrants further investigation, the findings suggest that it might offer some benefits worth considering for those affected by this challenging condition.
Read More
4
We examined the impact of omega-3 polyunsaturated fatty acids, particularly eicosapentaenoic acid (EPA), on chronic fatigue syndrome (CFS). Our research included 22 CFS patients and 12 healthy controls, where we measured serum levels of these fatty acids using advanced techniques.
Our findings revealed that CFS patients had elevated levels of omega-6 fatty acids while showing significantly lower ratios of omega-3 to omega-6. This imbalance was closely linked to the severity of CFS symptoms like fatigue and memory issues. We also found interesting connections between lower omega-3 levels and reduced serum zinc, hinting at immune system challenges present in CFS.
Notably, the study suggests that a decrease in omega-3 fatty acids could influence the immune response in those suffering from CFS. This outcome opens avenues for potential treatment strategies using omega-3 supplements like EPA. However, we did not have direct evidence of treatment outcomes, so while the results are promising, further investigation is needed to clarify how effective eicosapentaenoic acid might be as a treatment for CFS.
Our findings revealed that CFS patients had elevated levels of omega-6 fatty acids while showing significantly lower ratios of omega-3 to omega-6. This imbalance was closely linked to the severity of CFS symptoms like fatigue and memory issues. We also found interesting connections between lower omega-3 levels and reduced serum zinc, hinting at immune system challenges present in CFS.
Notably, the study suggests that a decrease in omega-3 fatty acids could influence the immune response in those suffering from CFS. This outcome opens avenues for potential treatment strategies using omega-3 supplements like EPA. However, we did not have direct evidence of treatment outcomes, so while the results are promising, further investigation is needed to clarify how effective eicosapentaenoic acid might be as a treatment for CFS.
Read More
User Reviews
USERS' SCORE
Good
Based on 12 Reviews
8.5
- All Reviews
- Positive Reviews
- Negative Reviews
9
Fatigue disappeared
103 people found this helpful
Excellent value for money and quality! I have taken this omega for over a month and it's given me a remarkable boost in energy throughout the day! As a parent, sleepless nights leave me feeling broken, but since I started this omega, my fatigue has vanished! Additionally, it has improved my skin and nails significantly!
Read More
9
Fatigue vanished
73 people found this helpful
I quickly wanted to share my review of this omega, having taken it for over a month. It's provided me an astounding energy boost daily! As a parent, I know sleep is often disrupted, leading to a tired feeling, but since taking this omega, my fatigue has disappeared. Plus, it's enhanced the condition of my skin and nails!
Read More
9
Fatigue relief
2 people found this helpful
As a doctor, I highly recommend this omega! It has the best DHA/EPA ratio, enhancing absorption. While pregnant, it completely alleviated my fatigue, and my skin has improved. It's also economical, lasting six months.
Read More
9
Fatigue improvement observed
I believe the omega 3 sourced from pollock in the pristine waters of Alaska is effective, albeit the pills are rather large. However, after a few days of taking them, my chronic fatigue syndrome has markedly improved and I find myself eating with greater satisfaction.
Read More
9
Energising effect
This omega provides me with an incredible burst of energy throughout the day! Despite sleepless nights with my child, I feel revitalised since starting it. It also promotes beautiful skin and nails.
Read More
Frequently Asked Questions
9
Fatigue improvement observed
I believe the omega 3 sourced from pollock in the pristine waters of Alaska is effective, albeit the pills are rather large. However, after a few days of taking them, my chronic fatigue syndrome has markedly improved and I find myself eating with greater satisfaction.
9
Fatigue disappeared
103 people found this helpful
Excellent value for money and quality! I have taken this omega for over a month and it's given me a remarkable boost in energy throughout the day! As a parent, sleepless nights leave me feeling broken, but since I started this omega, my fatigue has vanished! Additionally, it has improved my skin and nails significantly!
9
Fatigue vanished
73 people found this helpful
I quickly wanted to share my review of this omega, having taken it for over a month. It's provided me an astounding energy boost daily! As a parent, I know sleep is often disrupted, leading to a tired feeling, but since taking this omega, my fatigue has disappeared. Plus, it's enhanced the condition of my skin and nails!
9
Energising effect
This omega provides me with an incredible burst of energy throughout the day! Despite sleepless nights with my child, I feel revitalised since starting it. It also promotes beautiful skin and nails.
7.5
Effective treatment
I can feel the benefits due to the high content. My dry eye syndrome has notably improved, and the price is reasonable compared to the quantity provided.
0
Caused fatigue
Although this company offers high-quality products, this one triggered fatigue and headaches for me, which made it unsuitable despite its high price.
9
Fatigue relief
2 people found this helpful
As a doctor, I highly recommend this omega! It has the best DHA/EPA ratio, enhancing absorption. While pregnant, it completely alleviated my fatigue, and my skin has improved. It's also economical, lasting six months.
4
We examined the impact of omega-3 polyunsaturated fatty acids, particularly eicosapentaenoic acid (EPA), on chronic fatigue syndrome (CFS). Our research included 22 CFS patients and 12 healthy controls, where we measured serum levels of these fatty acids using advanced techniques.
Our findings revealed that CFS patients had elevated levels of omega-6 fatty acids while showing significantly lower ratios of omega-3 to omega-6. This imbalance was closely linked to the severity of CFS symptoms like fatigue and memory issues. We also found interesting connections between lower omega-3 levels and reduced serum zinc, hinting at immune system challenges present in CFS.
Notably, the study suggests that a decrease in omega-3 fatty acids could influence the immune response in those suffering from CFS. This outcome opens avenues for potential treatment strategies using omega-3 supplements like EPA. However, we did not have direct evidence of treatment outcomes, so while the results are promising, further investigation is needed to clarify how effective eicosapentaenoic acid might be as a treatment for CFS.
Our findings revealed that CFS patients had elevated levels of omega-6 fatty acids while showing significantly lower ratios of omega-3 to omega-6. This imbalance was closely linked to the severity of CFS symptoms like fatigue and memory issues. We also found interesting connections between lower omega-3 levels and reduced serum zinc, hinting at immune system challenges present in CFS.
Notably, the study suggests that a decrease in omega-3 fatty acids could influence the immune response in those suffering from CFS. This outcome opens avenues for potential treatment strategies using omega-3 supplements like EPA. However, we did not have direct evidence of treatment outcomes, so while the results are promising, further investigation is needed to clarify how effective eicosapentaenoic acid might be as a treatment for CFS.
9.5
We explored the potential benefits of eicosapentaenoic acid (EPA), an essential fatty acid, in treating chronic fatigue syndrome (CFS). A female patient with a six-year history of persistent CFS symptoms participated in the study, receiving a daily supplement rich in EPA.
After measuring her brain structure through high-resolution magnetic resonance imaging both at the beginning and 16 weeks later, we observed significant improvements in her symptoms starting just six to eight weeks into the treatment. Most notably, the patient's lateral ventricular volume—a key indicator of brain health—decreased from 28,940 mm³ to 23,660 mm³, indicating structural changes in her brain.
This research hints at the promising role of EPA in alleviating symptoms of chronic fatigue syndrome while also suggesting positive brain changes associated with treatment. The findings encourage further investigation into fatty acid supplementation's potential as an effective therapeutic strategy for CFS.
After measuring her brain structure through high-resolution magnetic resonance imaging both at the beginning and 16 weeks later, we observed significant improvements in her symptoms starting just six to eight weeks into the treatment. Most notably, the patient's lateral ventricular volume—a key indicator of brain health—decreased from 28,940 mm³ to 23,660 mm³, indicating structural changes in her brain.
This research hints at the promising role of EPA in alleviating symptoms of chronic fatigue syndrome while also suggesting positive brain changes associated with treatment. The findings encourage further investigation into fatty acid supplementation's potential as an effective therapeutic strategy for CFS.
9
Eicosapentaenoic acid shows promise
We examined the link between chronic fatigue syndrome (CFS) and essential fatty acids, focusing specifically on eicosapentaenoic acid (EPA). This investigation arose from various studies highlighting the potential role essential fatty acids play in alleviating symptoms associated with CFS.
Our approach involved administering a high-EPA supplementation to a group of individuals diagnosed with chronic fatigue syndrome. After following these patients for eight to twelve weeks, we observed that all participants experienced notable improvements in their symptoms.
These positive changes align with recent findings that discuss both cerebral and clinical benefits tied to increased EPA intake. Given these encouraging results, eicosapentaenoic acid may ultimately provide hope for many suffering from chronic fatigue syndrome.
Our approach involved administering a high-EPA supplementation to a group of individuals diagnosed with chronic fatigue syndrome. After following these patients for eight to twelve weeks, we observed that all participants experienced notable improvements in their symptoms.
These positive changes align with recent findings that discuss both cerebral and clinical benefits tied to increased EPA intake. Given these encouraging results, eicosapentaenoic acid may ultimately provide hope for many suffering from chronic fatigue syndrome.
8
Eicosapentaenoic acid's potential in CFS
We explored the connection between eicosapentaenoic acid (EPA) and chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis. The research indicates that individuals suffering from CFS may experience complications linked to persistent viral infections, which could hinder their body's ability to produce necessary fatty acids.
Specifically, the issue revolves around the enzyme delta-6 desaturase, which plays a critical role in the conversion of essential fatty acids like alpha-linolenic acid and linoleic acid into longer chain polyunsaturated fatty acids. These fatty acids are vital for maintaining healthy cell membranes and proper cell signaling. If their production is inhibited, it could explain many symptoms associated with CFS.
One intriguing aspect we observed is the potential therapeutic role that EPA could play. By providing EPA directly, we may bypass some of the metabolic restrictions caused by viral infections. This not only aids in generating essential fatty acids needed for bodily functions but also shows promise as a treatment option that could alleviate certain symptoms of CFS.
While the exact impact of EPA treatment on CFS warrants further investigation, the findings suggest that it might offer some benefits worth considering for those affected by this challenging condition.
Specifically, the issue revolves around the enzyme delta-6 desaturase, which plays a critical role in the conversion of essential fatty acids like alpha-linolenic acid and linoleic acid into longer chain polyunsaturated fatty acids. These fatty acids are vital for maintaining healthy cell membranes and proper cell signaling. If their production is inhibited, it could explain many symptoms associated with CFS.
One intriguing aspect we observed is the potential therapeutic role that EPA could play. By providing EPA directly, we may bypass some of the metabolic restrictions caused by viral infections. This not only aids in generating essential fatty acids needed for bodily functions but also shows promise as a treatment option that could alleviate certain symptoms of CFS.
While the exact impact of EPA treatment on CFS warrants further investigation, the findings suggest that it might offer some benefits worth considering for those affected by this challenging condition.
References
- Puri BK. Long-chain polyunsaturated fatty acids and the pathophysiology of myalgic encephalomyelitis (chronic fatigue syndrome). J Clin Pathol. 2007;60:122.
- Maes M, Mihaylova I, Leunis JC. In chronic fatigue syndrome, the decreased levels of omega-3 poly-unsaturated fatty acids are related to lowered serum zinc and defects in T cell activation. Neuro Endocrinol Lett. 2005;26:745.
- Puri BK, Holmes J, Hamilton G. Eicosapentaenoic acid-rich essential fatty acid supplementation in chronic fatigue syndrome associated with symptom remission and structural brain changes. Int J Clin Pract. 2004;58:297.
- Puri BK. The use of eicosapentaenoic acid in the treatment of chronic fatigue syndrome. Prostaglandins Leukot Essent Fatty Acids. 2004;70:399.
- Behan PO, Behan WM, Horrobin D. Effect of high doses of essential fatty acids on the postviral fatigue syndrome. Acta Neurol Scand. 1990;82:209.
